This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Resumen de acción VIVO
VIVO Cannabis Inc. produces and sells cannabis products for the medical and adult-use markets in Canada, Germany, and Australia.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Competidores de VIVO Cannabis Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.025 |
| 52 Week High | CA$0.075 |
| 52 Week Low | CA$0.015 |
| Beta | 2.12 |
| 1 Month Change | 25.00% |
| 3 Month Change | 0% |
| 1 Year Change | -66.67% |
| 3 Year Change | -87.80% |
| 5 Year Change | -98.18% |
| Change since IPO | -97.52% |
Noticias y actualizaciones recientes
Rentabilidad de los accionistas
| VIVO | CA Pharmaceuticals | Mercado CA | |
|---|---|---|---|
| 7D | 25.0% | -4.5% | 1.2% |
| 1Y | -66.7% | 55.7% | 11.8% |
Rentabilidad vs. Industria: VIVO matched the Canadian Pharmaceuticals industry which returned -67.5% over the past year.
Rentabilidad vs. Mercado: VIVO underperformed the Canadian Market which returned -8.7% over the past year.
Volatilidad de los precios
| VIVO volatility | |
|---|---|
| VIVO Average Weekly Movement | 38.1% |
| Pharmaceuticals Industry Average Movement | 14.4% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CA Market | 17.9% |
| 10% least volatile stocks in CA Market | 2.9% |
Precio estable de las acciones: VIVO's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: VIVO's weekly volatility has increased from 25% to 38% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| n/a | 155 | Ray Laflamme | vivocannabis.com |
Resumen de fundamentos de VIVO Cannabis Inc.
| Estadísticas fundamentales de VIVO | |
|---|---|
| Capitalización bursátil | CA$9.27m |
| Beneficios(TTM) | -CA$48.41m |
| Ingresos (TTM) | CA$25.41m |
0.4x
Ratio precio-ventas (PS)-0.2x
Ratio precio-beneficio (PE)¿Está VIVO sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de VIVO | |
|---|---|
| Ingresos | CA$25.41m |
| Coste de los ingresos | CA$17.30m |
| Beneficio bruto | CA$8.11m |
| Otros gastos | CA$56.53m |
| Beneficios | -CA$48.41m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.13 |
| Margen bruto | 31.93% |
| Margen de beneficio neto | -190.52% |
| Ratio deuda/patrimonio | 8.1% |
¿Cómo se ha desempeñado VIVO a largo plazo?
Ver rendimiento hist órico y comparativa